Toripalimab in HCC: New-Gen Immunotherapy in Liver Cancer
Key Takeaways
- New immunotherapy option for liver cancer
- HCC treatment landscape is evolving
- Combination with targeted therapy
- Patient selection criteria
Who is this video for?
Questions to ask your doctor
- What immunotherapy options are available?
- How is liver function monitored during treatment?
Have questions about this topic?
Suchi can summarize key points and help you prepare questions for your doctor.
Ask Suchi about this video
